fda compounding semaglutide crackdown news today 2025 National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA crackdown on off-brand Ozempic

RD: Conceptualization, Writing original draft

Patients with a history of pancreatitis should be evaluated carefully before initiating treatment with Semaglutide / Cyanocobalamin Injection, as GLP-1 receptor agonists have been associated with acute pancreatitis in post-marketing surveillance, though a definitive causal relationship has not been established

Pfizer decided to scrap its trial of danuglipron, an experimental oral GLP-1 agonist, after the once-daily drug caused liver injury in a phase 3 trial participant

GIP: Enhances the GLP-1 effect and improves feelings of fullness

Additionally, the launch Continue reading #Europe #HealthMedicine #PharmaceuticalsBiotech #Science #US To view or add a comment, sign in Boehringer Ingelheim spent #ADA2026 pointing to survodutide's targeted weight loss, but the latest data couldnt shake off concerns about the obesity drugs tolerability, Fraiser Kansteiner reports To view or add a comment, sign in Diabetes isn't just a disease anymore